xml version="1.0" encoding="UTF-8"?


L\_2008194EN.01004202.xml


| | | | |
| --- | --- | --- | --- |
| 23.7.2008 | EN | Official Journal of the European Union | L 194/42 |

---

Corrigendum to Commission Regulation (EC) No 1352/2007 of 16 November 2007 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Customs Tariff

(
[Official Journal of the European Union L 303 of 21 November 2007](http://publications.europa.eu/resource/oj/JOL_2007_303_R_TOC)
)

On page 4, in the Annex:

for:

‘ANNEX

In Chapter 15 of Annex I to Regulation (EEC) No 2658/87, Additional note 2 is amended as follows:

| | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (1) | Additional note 2.B.1 is amended as follows: | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | (a) | Point (a) is replaced by the following: | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | “(a) | one of the following wax contents: | | | | --- | --- | | (i) | a wax content not more than 300 mg/kg or | | | | | | | | | --- | --- | --- | --- | --- | --- | | (ii) | a wax content more than 300 mg/kg but not more than 350 mg/kg provided that: | | | | --- | --- | | — | the total aliphatic alcohol content is not more than 350 mg/kg or | | | | | --- | --- | | — | the erythrodiol and uvaol content is not more than 3,5 %.” | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | (b) | Point (c) is replaced by the following: | | | | | | | | --- | --- | --- | --- | --- | --- | | “(c) | one of the following two characteristics: | | | | --- | --- | | (i) | a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids; | | | | | --- | --- | | (ii) | a content in 2-glyceryl monopalmitate not more than 1,1 % if palmitic acid is not more than 14 % of the total content in fatty acids;” | | | |

| | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (2) | Additional note 2.B.2 is amended as follows: | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | (a) | Point (ij) is replaced by the following: | | | | | | | | --- | --- | --- | --- | --- | --- | | “(ij) | one of the following two characteristics: | | | | --- | --- | | (i) | a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids; | | | | | --- | --- | | (ii) | content in 2-glyceryl monopalmitate not more than 1,0 % if palmitic acid is not more than 14 % of the total content in fatty acids;” | | | | | | | | | --- | --- | --- | --- | | (b) | Point (l) is replaced by the following: | | | | --- | --- | | “(l) | a content in stigmastadienes not more than 0,10 mg/kg;” | | |

| | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| (3) | In additional note 2.C point (f) is replaced by the following: | | | | | | | | --- | --- | --- | --- | --- | --- | | “(f) | one of the following two characteristics: | | | | --- | --- | | (i) | a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids; | | | | | --- | --- | | (ii) | a content in 2-glyceryl monopalmitate not more than 1,0 % if palmitic acid is not more than 14 % of the total content in fatty acids;” | | |

| | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (4) | In additional note 2.D points (a) – (d) are replaced by the following points (a) – (e): | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | “(a) | one of the following wax contents: | | | | --- | --- | | (i) | a wax content more than 350 mg/kg or | | | | | | | | | --- | --- | --- | --- | --- | --- | | (ii) | a wax content more than 300 mg/kg but not more than 350 mg/kg provided that: | | | | --- | --- | | — | the total aliphatic alcohol content is more than 350 mg/kg and | | | | | --- | --- | | — | the erythrodiol and uvaol content is more than 3,5 %. | | | | | | | --- | --- | | (b) | an erythrodiol and uvaol content more than 4,5 %; | | | | | --- | --- | | (c) | a content in 2-glyceryl monopalmitate not more than 1,4 %; | | | | | --- | --- | | (d) | the sum of transoleic isomers not more than 0,20 % and the sum of translinoleic + translinolenic isomers not more than 0,10 %; | | | | | --- | --- | | (e) | a difference between the HPLC and theoretical content of triglycerides with ECN42 of not more than 0,6.” | |

| | |
| --- | --- |
| (5) | In additional note 2.E the second sentence is replaced by the following: “Oils of this subheading must have a content in 2-glyceryl monopalmitate not more than 1,4 %, a sum of transoleic isomers of less than 0,4 %, a sum of translinoleic + translinolenic isomers of less than 0,35 % and a difference between the HPLC and theoretical content of triglycerides with ECN42 not more than 0,5.” ’ |

read:

‘ANNEX

In Chapter 15 of Annex I to Regulation (EEC) No 2658/87, Additional note 2 is amended as follows:

| | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (1) | Additional note 2.B.1 is amended as follows: | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | (a) | Point (a) is replaced by the following: | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | “(a) | one of the following wax contents: | | | | --- | --- | | (i) | a wax content not exceeding 300 mg/kg; or | | | | | | | | | --- | --- | --- | --- | --- | --- | | (ii) | a wax content exceeding 300 mg/kg but not exceeding 350 mg/kg provided that: | | | | --- | --- | | — | the total aliphatic alcohol content is less than or equal to 350 mg/kg, or | | | | | --- | --- | | — | the erythrodiol and uvaol content is less than or equal to 3,5 %.” | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | (b) | Point (c) is replaced by the following: | | | | | | | | --- | --- | --- | --- | --- | --- | | “(c) | one of the following two characteristics: | | | | --- | --- | | (i) | a content in 2-glyceryl monopalmitate not exceeding 0,9 % if palmitic acid does not exceed 14% of the total content in fatty acids; | | | | | --- | --- | | (ii) | a content in 2-glyceryl monopalmitate not exceeding 1,1 % if palmitic acid exceeds 14 % of the total content in fatty acids;” | | | |

| | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (2) | Additional note 2.B.2 is amended as follows: | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | (a) | Point (ij) is replaced by the following: | | | | | | | | --- | --- | --- | --- | --- | --- | | “(ij) | one of the following two characteristics: | | | | --- | --- | | (i) | a content in 2-glyceryl monopalmitate not exceeding 0,9 % if palmitic acid does not exceed 14 % of the total content in fatty acids; | | | | | --- | --- | | (ii) | a content in 2-glyceryl monopalmitate not exceeding 1,0% if palmitic acid exceeds 14% of the total content in fatty acids”; | | | | | | | | | --- | --- | --- | --- | | (b) | Point (l) is replaced by the following: | | | | --- | --- | | “(l) | a content in stigmastadienes not exceeding 0,10 mg/kg;” | | |

| | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| (3) | In additional note 2.C, point (f) is replaced by the following: | | | | | | | | --- | --- | --- | --- | --- | --- | | “(f) | one of the following two characteristics: | | | | --- | --- | | (i) | a content in 2-glyceryl monopalmitate not exceeding 0,9% if palmitic acid does not exceed 14% of the total content in fatty acids; | | | | | --- | --- | | (ii) | a content in 2-glyceryl monopalmitate not exceeding 1,0% if palmitic acid exceeds 14% of the total content in fatty acids;” | | |

| | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (4) | In additional note 2.D, points (a) – (d) are replaced by the following points (a) – (e): | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | “(a) | one of the following wax contents: | | | | --- | --- | | (i) | a wax content higher than 350 mg/kg; or | | | | | | | | | --- | --- | --- | --- | --- | --- | | (ii) | a wax content exceeding 300 mg/kg but not exceeding 350 mg/kg provided that: | | | | --- | --- | | — | the total aliphatic alcohol content is above 350 mg/kg, and | | | | | --- | --- | | — | the erythrodiol and uvaol content is greater than 3,5 %. | | | | | | | --- | --- | | (b) | an erythrodiol and uvaol content higher than 4,5 %; | | | | | --- | --- | | (c) | a content in 2-glyceryl monopalmitate not exceeding 1,4 %; | | | | | --- | --- | | (d) | the sum of transoleic isomers not exceeding 0,20 % and the sum of translinoleic + translinolenic isomers not exceeding 0,10 %; | | | | | --- | --- | | (e) | a difference between the HPLC and theoretical content of triglycerides with ECN42 of 0,6 or less.” | |

| | |
| --- | --- |
| (5) | In additional note 2.E the second sentence is replaced by the following: “Oils of this subheading must have a content in 2-glyceryl monopalmitate not exceeding 1,4 %, a sum of transoleic isomers of less than 0,4 %, a sum of translinoleic + translinolenic isomers of less than 0,35 % and a difference between the HPLC and theoretical content of triglycerides with ECN42 not exceeding 0,5.” ’ |

---